CLINICAL_TRIALS
trial_result
· 2014-08-26
Clinical Trial Update: Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 4]
Summary
Phase 4 trial evaluating efficacy and tolerability in severe COPD; study completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Status: COMPLETED | Results posted: 2014-08-26